Firazyr and Nosebleed - a phase IV clinical study of FDA data
Summary:
Nosebleed is reported as a side effect among people who take Firazyr (icatibant acetate), especially for people who are female, 40-49 old, also take Seroquel, and have Immune system disorder.
The phase IV clinical study analyzes which people have Nosebleed when taking Firazyr. It is created by eHealthMe based on reports of 5,648 people who have side effects when taking Firazyr from the FDA, and is updated regularly.
What is Firazyr?
Firazyr has active ingredients of icatibant acetate. eHealthMe is studying from 5,650 Firazyr users. Check the latest studies of Firazyr.
What is Nosebleed?
Nosebleed (bleeding from nose) is found to be associated with 2,080 drugs and 3,091 conditions by eHealthMe. Check the latest studies of Nosebleed.
5,648 people reported to have side effects when taking Firazyr.
Among them, 12 people (0.21%) have Nosebleed.

Among these 12 people:
What is the gender of people who have Nosebleed when taking Firazyr? *
- female: 83.33 %
- male: 16.67 %
What is the age of people who have Nosebleed when taking Firazyr? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 66.67 %
- 50-59: 0.0 %
- 60+: 33.33 %
What are other drugs people take besides Firazyr? *
- Zoloft: 6 people, 50.00%
- Zofran: 6 people, 50.00%
- Zembrace Symtouch: 6 people, 50.00%
- Lamictal: 6 people, 50.00%
- Synthroid: 6 people, 50.00%
- Lunesta: 6 people, 50.00%
- Seroquel: 6 people, 50.00%
- Coenzyme Q10: 4 people, 33.33%
- Onzetra Xsail: 3 people, 25.00%
- Lithium Carbonate: 3 people, 25.00%
What are other side effects people have besides Nosebleed? *
- Hereditary Angioedema (recurrent episodes of severe swelling): 12 people, 100.00%
- Bacterial Infection: 5 people, 41.67%
- Weight Increased: 4 people, 33.33%
- Kidney Infection: 4 people, 33.33%
- Injection Site Bruising: 4 people, 33.33%
- Headache (pain in head): 4 people, 33.33%
- Bleeding Into The Skin: 4 people, 33.33%
- Wound Secretion: 2 people, 16.67%
- Weight Decreased: 2 people, 16.67%
- Peripheral Swelling: 2 people, 16.67%
What are the existing conditions these people have? *
- Immune System Disorder: 12 people, 100.00%
- Hereditary Angioedema (recurrent episodes of severe swelling): 8 people, 66.67%
* Approximation only. Some reports may have incomplete information.
Do you take Firazyr and have Nosebleed?
- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Firazyr:
- Firazyr (5,650 reports)
Nosebleed treatments and more:
- Nosebleed (92,075 reports)
How severe was Nosebleed and when was it recovered:
Expand to all the drugs that have ingredients of icatibant acetate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Firazyr:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Nosebleed:
- Nosebleed (2,080 drugs)
Browse all the conditions that are associated with Nosebleed:
- Nosebleed (3,091 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on icatibant acetate (the active ingredients of Firazyr) and Firazyr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Famvir and Thalidomide - 5 seconds ago
- Vaginal Bleeding Between Periods and Sleep Disorder - 15 seconds ago
- Drug interactions of Prednisone and Viorele - 33 seconds ago
- Could Methotrexate cause Cerebral Microangiopathy? - 33 seconds ago
- Drug interactions of Vioxx and Lac-Hydrin - 42 seconds ago
- Drug interactions of Fluconazole and Mucinex - 46 seconds ago
- Could Azopt cause Asthma? - a minute ago
- Drug interactions of Ms Contin and Fish Oil - a minute ago
- Could Buspirone Hcl cause Feeling Of Despair? - a minute ago
- Major Depression and Blood Glucose Increased - a minute ago